The balance between matrix metalloproteinases (MMPs) 
INTRODUCTION
Matrix metalloproteinases (MMPs) are a family of calcium-dependent, zinc-containing endopeptidases that are structurally and functionally related (1) . They are secreted in an inactive (latent) form, which is called a zymogen or a pro-MMP. These latent MMPs require an activation step before they are able to cleave extracellular matrix (ECM) components (1) . The activity of MMPs is regulated by several types of inhibitors, of which the tissue inhibitors of metalloproteinases (TIMPs) are the most important (2) . The TIMPs are also secreted proteins, but they may be located at the cell surface in association with membrane-bound MMPs (3) . The balance between MMPs and TIMPs is largely responsible for the control of degradation of ECM proteins (4) . MMPs are involved in the remodeling of tissues during embryonic development, cell migration, wound healing, and tooth development (5) (6) (7) (8) . However, a deregulation of the balance between MMPs and TIMPs is a characteristic of diverse pathological conditions, such as rheumatoid and osteoarthritis, cancer progression, and acute and chronic cardiovascular diseases (3, 9, 10) . To analyze the role of MMPs and TIMPs in tissue remodeling under normal and pathological conditions, it is important to have reliable detection methods. This review will briefly describe all known MMPs, their activation, and their role in tissue remodeling and pathology. It will focus on zymographical techniques for the analysis of MMPs and TIMPs.
THE MMP FAMILY
The family of human MMPs consists of 23 different forms that are divided into six groups (11) (12) (13) (14) . In order to classify the MMPs, knowledge of their characteristics is essential. It has been shown that each MMP consists of a specific domain sequence with several domain motifs. This sequence includes the signal peptide, the propeptide domain, the catalytic domain, and the C-terminal hemopexin-like domain, which are present in almost all MMPs (15). However, several MMPs have additional domains such as a transmembrane or a cytoplasmic domain (15,16). The organization of the MMP domains, together with their substrate specificity and sequence similarity, define the MMP classification. Six groups can be distinguished (Table 1 ; subgroups 1-6). (1.) The collagenase group includes MMP-1, MMP-8, and MMP-13. These are generally able to cleave the interstitial collagens I, II, and III. Collagenases are also able to digest certain other ECM and non-ECM proteins (8, 12, 17) . (2.) The gelatinase group, which consists of MMP-2 and MMP-9, mainly digests gelatin, the denatured form of collagen (8, 12) . (3.) The stromelysins, MMP-3 and MMP-10, digest ECM components such as collagen IV and fibronectin. MMP-11 is also called stromelysin-3, but its sequence and substrate specificity are different from that of MMP-3 and MMP-10. Therefore, MMP-11 is usually placed in the heterogeneous subgroup (see subgroup 6) (8, 12, 17) . This group includes MMP-12,  MMP-19, MMP-20, MMP-21, MMP-23, MMP-27, and MMP-28 (8,12) , which cleave substrates such as elastin and aggrecan (23,24). The classification presented here is a general one, and several other classifications are used (4, 8, 12, 17) . The main difference between these classifications is the assignment of the matrilysins, which are sometimes designated separately or to the stromelysins or the heterogeneous subgroup (4, 8, 12, 17) .
In healthy tissues, some MMPs such as MMP-7, MMP-19, MMP-24, MMP-25, and MMP-26 are expressed at low levels (25) . Many of the other MMPs, such as MMP-1, MMP-3, MMP-9, MMP-10, MMP-11, and MMP-13 are absent or only marginally expressed in normal, healthy, resting tissues. During repair or remodeling processes and in diseased or inflamed tissues, MMP expression is often increased (25, 26) .
ACTIVATION OF MMPs
MMP activity is regulated at multiple levels, such as at the level of gene transcription and the synthesis of pro-MMPs. Furthermore, the activation of proenzymes and the inhibition of MMPs by TIMPs are important regulatory processes. MMPs are secreted in a latent form as proMMPs, which require activation. In the propeptide domain of the MMPs, a cysteine residue (Cys 73 ) is present, which functions as a stabilizer of the inactive proenzyme (27, 28) . In the catalytic domain, an active Zn 2+ site is present, which forms a bond with the cysteine residue. When this Cys 73 -Zn 2+ bond is intact, the MMP is inactive ( Figure  1 ). The activation of MMPs involves a disruption of the bond between the active Zn 2+ site and the cysteine residue. This mechanism has been referred to as the "cysteine switch" (27, 28) . A water molecule then binds to the Zn 2+ ion and replaces the cysteine residue after the dissociation (27) . The noncatalytic zinc is then switched to a catalytic one, which results in an intermediate active enzyme (27) . Additionally, the pro-domain of the MMP is removed by autolytic cleavage or by other proteases (27, 28) . This cleavage causes a reduction in molecular mass and results in a fully active enzyme. The mass reduction is generally in the range of 8-10 kDa (29) . In vivo, MMPs are generally activated by other proteinases. In vitro, MMPs are also activated by chemical and physical agents such as aminophenylmercuric acetate (APMA), low pH, and heat treatment (12, 15, 27) .
THE ROLE OF MMPs IN NORMAL TISSUE REMODELING
MMP activity is mainly regulated by TIMPs, of which four human forms are known that can inhibit almost all MMPs tested thus far. Moreover, the TIMPs do not seem to differentiate much between the various MMPs (4,12). TIMPs have a high level of sequence heterogeneity, which suggests that they also have different functional properties (2) . For instance, in addition to inhibiting MMP activity, TIMPs also seem to have growth factor-like and antiangiogenic properties (30) . TIMPs generally inhibit the activity of MMPs by the formation of a 1:1 complex (12). Collagenase-1  Collagenase-2  Collagenase-3   Col I, II, III, VII, VIII, X, gelatin  Col I, II, III, VII, VIII, X, aggrecan, gelatin  Col I, II, III, IV, IX Normal and pathological tissue remodeling is regulated by the balance of MMPs and TIMPs within the tissue (4). The remodeling of tissues is essential for several aspects of normal physiology, including embryonic development, collagen turnover, tooth development, and cell migration but also in processes like wound healing (5-7). For instance, during the embryonic development in mice, mRNA levels for MMP-9 and MMP-13 and TIMP-1 are highly expressed in bone. Additionally, in embryonic epithelial tissues, mRNA for TIMP-3 is widely expressed (6) .
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THE ROLE OF MMPs IN PATHOLOGICAL TISSUE REMODELING
Numerous pathological conditions are caused by the disruption of the balance between MMPs and TIMPs (4) . Overproduction of MMPs is associated with tissue destruction in chronic inflammatory diseases such as rheumatoid and osteoarthritis (9, 10) . In both conditions, it appears that the erosion of cartilage is caused by an increased expression of MMPs such as MMP-1, MMP-8, and MMP-13, depending on the joint tested (9, 10) . In addition, the contribution of each MMP to the disease process may vary in each joint (31) . MMPs are also involved in tumor growth and metastasis (32) . In almost all human cancers, the MMP expression and activity are increased. In colon cancer, mainly MMP-7 is overexpressed (33, 34) . The increased levels of MMPs seem to correlate with invasiveness and poor prognosis (16). Deregulation of MMPs has also been implicated in distinct acute and chronic cardiovascular diseases, such as atherosclerosis, myocardial infarction, and heart failure (35, 36) . Several MMPs such as MMP-1 and MMP-9 are also known to influence the process of atherosclerotic lesion formation, but the mechanism is still not completely elucidated (22).
Many different MMPs are involved in normal tissue remodeling but also play a role in tissue resorption in pathological conditions. To prevent tissue degradation by a disturbed MMP-TIMP balance, it is important to know which MMPs and TIMPs are involved in the specific disease processes. Thus, the analysis of MMPs in biological samples can contribute to the characterization of certain diseases involving tissue destruction and possibly to the development of new therapies.
DETECTION OF MMPs
The expression of MMPs can be analyzed with several techniques. A widely used technique is substrate zymography, which identifies MMPs by the degradation of their preferential substrate and by their molecular weight.
Using this technique, one can determine whether the MMP is in an active or latent form. To localize MMPs in tissue sections, in situ zymography can be performed. TIMPs can be detected by reverse zymography, which is based on their ability to inhibit MMPs. These specific techniques will be discussed in the next sections.
SUBSTRATE ZYMOGRAPHY
Zymography and reverse zymography are described as simple, sensitive, quantifiable, and functional assays to analyze MMPs and TIMPs in biological samples (37, 38) . All types of substrate zymography originate from gelatin zymography. The techniques are the same except that the substrate differs depending on the type of MMPs or TIMPs to be detected. In zymography, the proteins are separated by electrophoresis under denaturing [sodium dodecyl sulfate (SDS)], nonreducing conditions. The separation occurs in a polyacrylamide gel containing a specific substrate that is co-polymerized with the acrylamide (39, 40) . During electrophoresis, the SDS causes the MMPs to denature and become inactive. The activation of latent MMPs during zymography is believed to involve the "cysteine switch" because the dissociation of Cys 73 from the zinc molecule is caused by SDS ( Figure 1 ; Reference 27). After electrophoresis, the gel is washed, which causes the exchange of the SDS with Triton ® X-100, after which the enzymes partially renature and recover their activity (39, 41) . Additionally, the latent MMPs are autoactivated without cleavage (42) . Subsequently, the gel is incubated in an appropriate activation buffer. During this incubation, the concentrated, renatured MMPs in the gel will digest the substrate (37, 40) . After incubation, the gel is stained with Coomassie ® Blue, and the MMPs are detected as clear bands against a blue background of undegraded substrate (37, 40) . The clear bands in the gel can be quantified by densitometry (41) . Zymography is based on the following principles: (i) during electrophoresis, gelatin is retained in the gel; (ii) MMP activity is reversibly inhibited by SDS REVIEW during electrophoresis; and (iii) the SDS causes the separation of MMP-TIMP complexes during electrophoresis. This enables the detection of MMPs and TIMPs independently of one another (37) . An additional advantage of zymography is that both the proenzymes and the active forms of MMPs can be distinguished on the basis of their molecular weight (41) . As mentioned before, SDS dissociates the TIMPs from the MMPs, which may result in a higher activity than in vivo. Because zymography only indicates whether the proenzyme displays in the presence of TIMP in vivo, it is uncertain how much activity such an active form would display in the presence of TIMP in vivo (41) . Additionally, the refolding of MMPs after electrophoresis recovers only part of the original activity. Furthermore, the digestion of gelatin by pro-MMPs is somewhat reduced because the latent form still retains its propeptide domain (41) .
Gelatin Zymography
Gelatin zymography is mainly used for the detection of the gelatinases, MMP-2 and MMP-9, respectively ( Figure 2 ). It is extremely sensitive because levels of 10 pg of MMP-2 can already be detected (43) . It should be considered, however, that other MMPs, such as MMP-1, MMP-8, and MMP-13 can also lyse the substrate. This signal will probably be very weak because gelatin is not their preferential substrate (44, 45) . For MMPs that do not show any activity on gelatin, modifications of the technique have been made for an improved detection. This is mainly done by incorporating a more suitable substrate into the gel, such as casein or collagen, or by enhancing the signal by adding heparin to the samples (40, 46, 47) .
Casein Zymography
Casein is a preferential substrate for the stromelysins including MMP-11, however, the native forms of MMP-11 show no caseinolytic activity (48) (49) (50) (51) (52) . Casein zymography is also suitable for the detection of MMP-1, MMP-7, MMP-12, and MMP-13 (53) (54) (55) (56) . In addition, MMP-9 can be detected when present in high concentrations. Unfortunately, casein zymography is much less sensitive than gelatin zymography. Furthermore, casein migrates in the gel during electrophoresis due to its relatively low molecular weight (23 kDa). This results in two clearly defined zones in the gel, the lower part that still contains excess casein and the upper part with less casein. The anodic migration of the casein is especially problematic in the case of MMPs that end up near the caseinmigration boundary, such as the latent and activated forms of MMP-7 (29 and 20 kDa, respectively; Reference 40). Prerunning the casein gel, allowing the excess casein to migrate out, can solve this. A second run of the gel does not cause any further migration of the casein, therefore eliminating its interference with the MMP bands. The amount of casein remaining in the gel is still sufficient for the detection of MMPs. According to the literature, the minimal detectable amount of purified recombinant MMP-7 is 1 ng, but 8 ng and more will give clear bands (40) .
Collagen Zymography
Collagen zymography is mainly used for the detection of MMP-1 and MMP-13, but MMP-2 and MMP-9 can also be detected (45, 57, 58) . The incorporation of native collagen fibers in polyacrylamide gels appears unsuitable for zymography because of their complicated structure, but SDS disrupts most of the fibrillar organization of the collagen, allowing proteins to run into the gel. After running the zymogram, the exchange of SDS and Triton X-100 during incubation restores part of the original triple-helical conformation of collagen, allowing its degradation by collagenases. In collagen zymography, amounts of 10 pg of pro-MMP-1 and 0.1 pg of active MMP-1 can be detected (47) . The band intensity of 1 pg of active MMP-1 is about equivalent to that of 22 pg of pro-MMP-1. This indicates the necessity to calibrate the signal of the pro-MMP-1 and active MMP-1 for accurate quantification (47) .
Heparin-Enhanced Substrate Zymography
MMP-7 and the collagenases are hard to detect at low levels in casein or gelatin zymography. It is possible to detect MMP-7 in carboxymethylated (CM) transferrin zymography, which is occasionally used, but often the signal is very low (59) (60) (61) . It is known that the extraction of MMPs from tissue in the presence of heparin results in an enhancement of MMP activity. The addition of heparin to the samples during or prior to electrophoresis also enhances MMP activity. The signal of intermediate and active MMP-7 can be enhanced about 5-fold by heparin in CM transferrin zymography and the detection of pro-MMP-7 can be enhanced even 20-fold (46, 61) . The mechanisms by which heparin seem to enhance MMP-7 activity in zymography are (i) the induction of a conformational change, (ii) the facilitation of refolding, (iii) the reduction of autolysis, or (iv) the increase of anchorage of the MMP in the gel (61) . In the case of pro-MMP-7, heparinenhanced CM transferrin zymography can detect as little as 30 pg/lane compared to about 750 pg without heparin. It is also possible to enhance the activity of MMP-1 and MMP-13 in gelatin zymography by adding heparin, which increases the sensitivity at least 5-fold (46) .
The heparin forms a wide band or "heparin box" in the gel that spans a region of about 15-30 kDa, thus covering the MMP-7 forms with a molecular weight of 19 and 28 kDa ( Figure 3A ) (46) . Only when the MMPs end up in the heparin box, the enhancement is optimal. To determine the location of the heparin box, a separate regular sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel must be run, on which heparin can be detected with an azure A staining for glycosaminoglycans. Because the active and latent forms of MMP-1 and MMP-13 are in the range of 40-60 kDa, heparin should be added to the lanes 20-30 min after the start of electrophoresis to ensure the co-migration of the MMPs and heparin (46) . Prestained molecular weight standards are also added together with the heparin to indicate its position. For instance, when the 31-kDa band of the secondary molecular weight standards line up with the 66 kDa band of the primary molecular weight standards, the heparin box will fall in the range 36-66 kDa of the first molecular weight standards ( Figure 3B ; Reference 46). In conclusion, it is important to position the heparin box correctly to achieve reliable results. This makes the method more complex than other, more common forms of zymography.
Reverse Zymography
Four human TIMPs are known of which only TIMP-3 occurs in a glycosylated and an unglycosylated form. They can be detected by reverse zymography, which is a modification of zymography for MMPs (37) . Besides gelatin, an MMP is also incorporated into the gel, usually MMP-2. During the activation step after electrophoresis, the MMP-2 only digests the gelatin in areas where TIMPs are absent. Thus, after staining, the gel will be colorless, except for the TIMP bands. In these bands, the TIMPs will inhibit MMP-2 activity by the formation of a 1:1 complex, and the gelatin will not be digested (62, 63) . This results in blue TIMP bands against a colorless background (37). The SDS in the gel dissociates any TIMPs bound to MMPs, and thus the total amount of TIMPs in the sample is detected (63) .
The cheapest way to perform reverse zymography is to incorporate conditioned medium with MMPs in the gel next to gelatin (62) . The conditioned medium should contain MMP-2 because all known TIMPs inhibit MMP-2 effectively (37). It is also possible to incorporate purified MMP-2, but this is far more expensive (64) . A typical reverse zymogram with incorporated purified MMP-2 shows two sections, a small upper section (section 1) and a wider middle section ( Figure 4A , section 2 and Figure 4C ; Reference 42). Section 1 contains no MMP-2 because it is migrated further into the gel. This section is therefore stained blue because of the presence of gelatin. Thus, in this section, it is possible to detect MMP activity (42) . Section 2 contains the MMP-2 and can be used for the detection of TIMPs (37) . It is also possible to use conditioned medium that contains both MMP-2 and TIMP-2 activity. Due to the presence of SDS, the MMP-TIMP complexes in the conditioned medium will dissociate, and both will migrate through the gel according to their molecular weights (72 and 20 kDa, respectively; Reference 37). This results in three distinct sections on the Coomassie blue-stained gel, a narrow upper section (section 1), a wide middle section (section 2), and a narrow lower section ( Figure 4B , section 3 and Figure 4D ; References 37 and 42). Section 1 contains neither MMP-2 nor TIMP-2. Section 2 contains only MMP-2, while TIMP-2 has migrated further downwards because of its smaller molecular weight. Section 3 contains MMP-2 and the remaining TIMP-2. Section 2 is the analytical part of the gel and is used for the detection of TIMP activity (37, 62) .
To obtain an increased effective range of the analytical section, the electrophoresis time can be prolonged. Furthermore, a longer stacking gel will increase the distance between any TIMP-2 from the sample and the TIMP-2 from the conditioned medium (37). It is not recommended to use conditioned medium that contains other TIMPs than TIMP-2, such as TIMP-1 (28 kDa), because its lower electrophoretic mobility yields a narrower analytical range in the gel (37) . When conditioned medium is used that contains 
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several MMPs, the background staining will consist of a pattern of horizontal regions, which renders the analysis of TIMPs inaccurate (42) .
For the analysis of a reverse zymogram, it is necessary to discriminate between the TIMP bands and the proteins that are present in the sample, which will also be stained by the Coomassie Blue (37) . Therefore, extracted tissue samples and total cell lysates from cultured cells can be particularly problematic. To avoid interference by endogenous proteins, samples should be electrophoresed at dilutions that do not allow detection of these proteins. Thus, a regular SDS-PAGE gel with the same sample should be run under identical conditions (37) . Bands that appear in the reverse zymogram and are not visible in the regular SDS gel must be TIMPs (37) . To obtain a reliable reverse zymogram, optimization of the gelatin and gelatinase concentration is required because this can dramatically increase the sensitivity (42) . Recently, realtime zymography and reverse zymography were developed, which use a fluorescein isothiocyanate (FITC)-labeled substrate (65) . With these techniques, the substrate degradation can be monitored continuously with a transilluminator. Another advantage is the higher sensitivity that is achieved with lower amounts of substrates (65) .
In Situ Zymography
In situ zymography allows the localization of MMPs in tissue sections (26, 66, 67) . It is an adaptation of substrate zymography that is suitable for frozen sections. The nature of the substrate dictates which MMP can be detected (68) . In situ zymography is a relatively low-cost technique (68) . Briefly, in situ zymography uses a substrate that is deposited on or under a frozen section of an unfixed tissue sample ( Figure 5 ; Reference 68). During incubation, the substrate will be digested by the activated MMPs in a time-and dose-dependent manner (68) . The degradation of the substrate is detected by light microscopy or fluorescence microscopy, depending on the type of substrate. For instance, gelatinolytic activity can be detected using a gelatincontaining photographic emulsion that is mixed with MMP activation buffer. MMPs present in the section can be detected due to exposure to ambient light during incubation and the subsequent photographic processing. The emulsion contains light-sensitive silver halide crystals that are evenly dispersed by gelatin. Photographic chemicals are allowed to reach the crystals when gelatin is not degraded by MMPs. This results in a chemical change of the crystals, leading to a black image. Chemicals are unable to penetrate the emulsion on spots where the gelatin is degraded, and white spots will appear. In conclusion, the MMP activity can be determined by light microscopy as white spots on a black background of undegraded substrate ( Figure 5A ; Reference 26). When using a fluorescent substrate, the degradation of the substrate causes loss of fluorescence, and the MMPs are then detected as black spots on a fluorescent background ( Figure 5B ; Reference 26) . A more sensitive modification of this method uses a quenched fluorogenic substrate (69) . When this substrate is cleaved, the MMPs are detected as strong fluorescent spots against a black background ( Figure 5C ; Reference 70) .
With in situ zymography, only active MMPs are detected, but by activating latent MMPs (i.e., with APMA), both forms are visible (71) . A limitation of this technique is that it may be difficult to discriminate between the different classes of MMPs (68). Additionally, not only can MMPs break down the substrates, but also serine, cysteine, or aspartic proteinases. Thus, it is essential to use control slides with appropriate MMP inhibitors (66) . The main obstacle for in situ zymography is the scarcity of specific substrates or specific inhibitors, although more and more of these substrates and molecules will become available. A relatively new substrate is a biocompatible near-infrared fluorogenic (NIRF) MMP probe, consisting of a quenched near-infrared fluorochrome and an MMP-2 substrate on a nonimmunogenic backbone (72) . When the substrate is cleaved, which occurs preferentially by MMP-2, the fluorescence intensity increases significantly. The probe can be used in live animals and can detect MMP activity within hours after injection (72) . After placing the animal in a light-tight chamber, the fluorogenic activity inside the animal can be visualized with an imaging system (73) . This technique has been developed to monitor MMP activity and their inhibition in tumors in vivo (72) .
For the specific detection and imaging of MMP-7 in tumors, the polymer-based fluorogenic substrate PB-M7VIS has been developed (74) .
Other new in situ zymography techniques are being developed, which have been named three-dimensional (3-D), 4-D, and 5-D in situ zymography (75) (76) (77) . In the 3-D technique, collagen with a quenched fluorescent label is copolymerized together with the cells in a 3-D collagen lattice. The degradation of collagen by MMPs from live cells is detected by measuring the fluorescent signal with confocal microscopy (76, 77) . The monitoring of the signal in the collagen lattices over time produces a 4-D technique (77) . The use of more than one fluorochrome to determine the localization of several MMPs in time generates 5-D information (http://www. ichc2004.org/PdfFolder/AbstractsAuthorIndex.pdf; SP8). The advantages of these techniques over normal in situ zymography are the possibility to monitor cell migration and cell shape changes in addition to the progression of substrate degradation (75) (76) (77) .
PROBLEMS
MMP Extraction
In media obtained from cell culture, it is relatively easy to detect MMPs and TIMPs. However, the extraction and analysis of MMPs and TIMPs from tissues are much more difficult. In the first place, the amount of MMPs and TIMPs in tissues is about 50 times lower than those found in conditioned medium (41) . Secondly, they are difficult to extract from tissues, and it is never certain whether all MMPs and TIMPs are extracted. Moreover, several MMPs, such as MMP-1, MMP-2, and MMP-9, are tightly bound to the ECM (41) . Another disadvantage of tissue extraction is the preclusion of the localization of MMPs. In addition, the extraction procedure can activate MMPs, but MMPs can also be inactivated by binding with their respective inhibitors, which may have been localized in distinct compartments in the intact cells or tissue (68) . Specific MMPs or TIMPs localized in a small REVIEW part of the tissue may not be detected because of its dilution in the entire tissue extract (68) . Because of these problems, it is difficult to determine the actual activity of MMPs in tissues. To localize MMPs in tissue in the presence of TIMPs, using in situ zymography is recommended. This technique reflects the endogenous balance of MMPs and TIMPs in the tissue, although quantification is not possible (68) .
Substrate Zymography
Sample preparation is very important when performing a zymography. The samples should not be boiled because the MMPs will lose their activity. Moreover, the addition of β-mercaptoethanol to the sample buffer is not recommended because it breaks the disulphide bonds of the MMPs. After the zymography, the MMPs will not be able to refold again, which causes a dramatic decrease in their activity (37) . It should be considered that the nonreducing conditions lead to slightly different migration characteristics of the MMPs and TIMPs compared with Western blot analysis (37) . It is also important to consider that SDS dissociates MMPs from TIMPs, and thus only indicates the presence of MMPs and TIMPs, but not the actual activity within the tissue.
The staining and destaining of the zymogram can lead to overstaining, which causes loss of sensitivity. Alternatively, it is possible to destain the gel too much, which bleaches the bands and makes them unsuitable for quantification (38) . Simply combining the staining and destaining solutions can solve this problem. It will also yield a fast and reproducible staining (38) . This single-step staining protocol was successfully used for the analysis of MMP-2 and MMP-9 in gelatin zymography and for MMP-7 in casein zymography (38) . Testing substrates from various sources might further increase the sensitivity of zymography or reverse zymography. Substrates can differ considerably in performance, especially in reverse zymography (37) . For every new substrate, it is necessary to determine the optimal substrate concentration, the most suitable conditioned medium, and the optimal running and developing conditions (37, 42) . Despite the optimization, specific MMPs might still not be detected because zymography is sometimes just not sensitive enough. In those cases, other assays might be more suitable, such as enzyme-linked immunosorbent assay (ELISA) or Western blot analysis. For example, MMP-8 is difficult to detect with zymography, but with other techniques it might be possible to measure protein levels (78, 79) .
In situ zymography is used for the identification and microscopic localization of MMPs within sections of unfixed frozen tissues. The MMPs are detected using a photographic emulsion or a fluorescent substrate. A disadvantage of the photographic method is the difficulty to standardize the method (80) . The slides cannot be coverslipped and are therefore more sensitive to variations in humidity during the incubation. Additionally, the thickness of the emulsion layer might be uneven and thereby reduce the quality of the results (80) . In contrast, with the fluorescent substrate, the substrate is deposited on the slide before applying the section. In this way, poorly coated glass slides can be detected by microscopic inspection before placing the tissue sections on the slides (80) . However, the sensitivity of this method is lower because higher levels of enzymatic activity are required to produce spots large enough for detection (68) . A more sensitive approach, which is often used nowadays, uses a highly quenched fluorescent substrate that fluoresces only after degradation. The enzymatic activity is observed as a fluorescent area against a darker, low fluorescent background (69) .
PROBLEMS WITH THE ANALYSIS
The identification of MMPs and TIMPs is often achieved by comparison with known molecular weight standards (37) . One should be aware that some commercially available molecular weight standards contain a reducing agent. When these standards are used under nonreducing conditions, they may indicate different molecular weights (37) . For a definite identification of MMPs and TIMPs, one must perform Western blot analysis using specific antibodies. Because zymography is much more sensitive than Western blot analysis, it might be difficult to find antibodies that are sensitive enough to detect small amounts of MMPs and TIMPs.
MMPs and TIMPs can be quantified after zymography using densitometry. The amounts of MMPs or TIMPs are determined by comparison with a standard curve of a purified enzyme (47) . However, complexes of MMPs might occur that complicate the analysis. MMP-9 can be associated with a 25-kDa protein (microglobulin), giving a band at 125 kDa and a dimer at 215 kDa. These complexes are not dissociated in zymography (81) . In Figure 2 , a band is found at 240 kDa that might represent a multimer or pro-MMP-9 (82). Also, several MMPs together can form complexes that can only be identified with specific antibodies in Western blot analysis.
Using in situ zymography, it is often not possible to discriminate between different MMPs because the substrates are usually degraded by more than one MMP. Specific MMPs should be identified by a complementary technique such as immunohistochemistry for valid conclusions (68) . The immunolocalization of MMPs can be compared with the localization pattern of the in situ zymography, which should be preferably performed on the same section or on serial sections (66) . Some very specific substrates for MMP-1, MMP-7, MMP-8, and MMP-13 are currently available, which are generally fluorescent peptides (45, 83, 88 
